Search company, investor...


Founded Year



Unattributed - IV | Alive

Total Raised


Last Raised

$2M | 22 yrs ago

About Neotonus

Neotonus is a medical device company which utilizes a non-invasive technology known as Extracorporeal Magnetic Innervation, or ExMI, initially targeted at urinary incontinence.

Headquarters Location

30 South Park Square

Marietta, Georgia, 30060,

United States


Missing: Neotonus's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Neotonus's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Neotonus Frequently Asked Questions (FAQ)

  • When was Neotonus founded?

    Neotonus was founded in 1997.

  • Where is Neotonus's headquarters?

    Neotonus's headquarters is located at 30 South Park Square, Marietta.

  • What is Neotonus's latest funding round?

    Neotonus's latest funding round is Unattributed - IV.

  • How much did Neotonus raise?

    Neotonus raised a total of $15.25M.

  • Who are the investors of Neotonus?

    Investors of Neotonus include Wakefield Group, Crown Advisors, AdventHealth, Noro-Moseley Partners and Antares Capital Corporation.

  • Who are Neotonus's competitors?

    Competitors of Neotonus include OrthAlign, Freedom Innovations, Uromedica, Solace Therapeutics, Stanmore Implants and 13 more.

Compare Neotonus to Competitors

Freedom Innovations Logo
Freedom Innovations

Freedom Innovations is a high technology provider of premium prosthetic devices, a growing segment of the non-invasive orthopedic market. It deals with making prosthetic devices with latest technological developments and customization for lower limb amputations. The branded carbon fiber foot products lead the industry in reputation and growth rate. The company's first microprocessor-controlled product, the Pli' MPC Knee, was introduced in May 2007, serving as an entry into the SMART technology arena.What aims to make the company and the products is the high customization in the prosthetic devices market ranging from different limbs for swimmers to bikers to soldiers and so on.In February 2012, Health Evolution Partners acquired a majority stake in Freedom Innovations. The valuation of Freedom Innovations was undisclosed. Other terms of the deal were not released.

Flowonix Medical Logo
Flowonix Medical

Flowonix designs, develops, and deploys targeted drug delivery platforms whose sole purpose is to provide physicians an optimal solution for the treatment of their patients' numerous neurological disorders.


NanoPowers aims to develop artificial muscles for various implant indications. The Company has developed several animal proof of concepts, and is entering preclinical stages with devices aimed for the treatment of urinary and fecal incontinences.

Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.


BioControl - New generation of active implantable devices affecting the behavior of muscles and nerves of the autonomic nervous system. The company sold its urology business for $90M to American Medical Systems.

S.A.M.O. S.p.A.

SAMO is present in the hospitals and in the operating rooms and for forty years it has been focusing on developing joint reconstruction implants and internal fixation products. Meanwhile the company aims to offer steadily he best technologies and service to the professionals who operate and implant the company's products in the field.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.